Capital is abundant, but conviction is scarce. In a repriced, more selective market, 2026 rewards investors who pair sharper sector theses with earlier, evidence-led preparation.

The mid-market enters the second half of 2026 in a curious position: rarely has there been so much capital available to deploy, and rarely have investors been so cautious about deploying it. Higher-for-longer financing costs, a wider bid-ask spread and a sharper focus on downside protection have all raised the bar. The result is a two-speed market - genuinely high-quality assets attract competitive, well-funded processes, while everything else struggles to clear.
For disciplined investors, that is not bad news. Selectivity rewards preparation. The firms winning the assets they want are not necessarily paying the most; they are the ones who understood the asset earliest, framed the thesis most clearly, and moved with conviction when it mattered.
Record levels of uncommitted capital are often read as a signal that deals will flow freely. The opposite has proved true. Abundant capital concentrates competition on the minority of assets that can withstand scrutiny, and it raises the cost of getting a view wrong. Committing capital is easy; committing it to the right asset, at the right price, with a credible plan to create value, is not.
Abundant capital has not made good deals easier to find - it has made discipline more valuable.
The most striking shift we see is where in the timeline conviction is formed. Increasingly it happens before a process even opens. That means:
By the time a data room opens, the best-prepared bidders already know what they are looking for and where the value - and the risk - is likely to sit.
Themes travel across sectors, but a few stand out: tech-enabled and recurring-revenue services, where quality of earnings is high and defensible; healthcare and life-sciences provision, supported by durable demand; and buy-and-build platforms in fragmented markets, where disciplined consolidation still compounds value. In each, the winners will be those who can separate a genuinely resilient business from one that simply looks attractive in a spreadsheet.
The practical implication is to move effort earlier. Origination, thesis development and preliminary diligence are no longer preparatory steps to be compressed at the end - they are where the deal is won or lost. In a selective market, the advantage goes to those who arrive with conviction, evidence and a plan.
We work with investors ahead of and through the deal life-cycle - sharpening the thesis, originating proprietary opportunities, and bringing forensic, AI-enabled diligence that tests conviction against the evidence. If you are refining where to focus your capital in 2026, we would be glad to compare notes.
Senior advisors, independent insight and the pace your timeline demands.